These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 34277043)
1. Soluble ST2 and mixed venous oxygen saturation for prediction of mortality in patients with pulmonary hypertension. Sun Y; Wang L; Meng X; Gong S; Zhao Q; Shi L; Jiang R; He J; Wu W; Li Y; Luo C; Qiu H; Li J; Yuan P; Liu J J Thorac Dis; 2021 Jun; 13(6):3478-3488. PubMed ID: 34277043 [TBL] [Abstract][Full Text] [Related]
2. Soluble ST2 in serum predicts the prognosis of idiopathic pulmonary fibrosis: a retrospective study. Yu YZ; Gui XH; Yu M; Huang W; Peng LY; Dai JH; Xu QQ; Zhao TT; Xie WP; Xiao YL; Yuan P; Li Y Ann Transl Med; 2022 Jul; 10(14):797. PubMed ID: 35965810 [TBL] [Abstract][Full Text] [Related]
3. The Prognostic Value of Soluble ST2 in Adults with Pulmonary Hypertension. Geenen LW; Baggen VJM; Kauling RM; Koudstaal T; Boomars KA; Boersma E; Roos-Hesselink JW; van den Bosch AE J Clin Med; 2019 Sep; 8(10):. PubMed ID: 31547136 [TBL] [Abstract][Full Text] [Related]
4. Soluble ST2 as a Potential Biomarker for Risk Assessment of Pulmonary Hypertension in Patients Undergoing TAVR? Boxhammer E; Mirna M; Bäz L; Bacher N; Topf A; Sipos B; Franz M; Kretzschmar D; Hoppe UC; Lauten A; Lichtenauer M Life (Basel); 2022 Mar; 12(3):. PubMed ID: 35330140 [TBL] [Abstract][Full Text] [Related]
5. The prognostic value of sST2 in connective tissue disease patients with pulmonary hypertension. Ye H; Wu Q; Zhang N; Shi J; Zhang H; Wang Q; Zhang M; Sun X Rheumatology (Oxford); 2022 Oct; 61(10):3989-3996. PubMed ID: 35094054 [TBL] [Abstract][Full Text] [Related]
6. Prognostic Value of Circulating sST2 for the Prediction of Mortality in Patients With Cardiac Light-Chain Amyloidosis. Zhang Y; Xiao Y; Liu Y; Fang Q; Tian Z; Li J; Zhou D; Xie Z; Dong R; Zhang S Front Cardiovasc Med; 2020; 7():597472. PubMed ID: 33553254 [No Abstract] [Full Text] [Related]
7. Increased plasma concentrations of soluble ST2 are predictive for 1-year mortality in patients with acute destabilized heart failure. Mueller T; Dieplinger B; Gegenhuber A; Poelz W; Pacher R; Haltmayer M Clin Chem; 2008 Apr; 54(4):752-6. PubMed ID: 18375488 [TBL] [Abstract][Full Text] [Related]
8. Plasma soluble ST2 levels correlate with disease severity and predict clinical worsening in patients with pulmonary arterial hypertension. Zheng YG; Yang T; He JG; Chen G; Liu ZH; Xiong CM; Gu Q; Ni XH; Zhao ZH Clin Cardiol; 2014 Jun; 37(6):365-70. PubMed ID: 25068163 [TBL] [Abstract][Full Text] [Related]
9. Mixed Venous Oxygen Saturation Is a Better Prognosticator Than Cardiac Index in Pulmonary Arterial Hypertension. Khirfan G; Almoushref A; Naal T; Abuhalimeh B; Dweik RA; Heresi GA; Tonelli AR Chest; 2020 Dec; 158(6):2546-2555. PubMed ID: 32629034 [TBL] [Abstract][Full Text] [Related]
10. ST2 as a novel prognostic marker in end-stage renal disease patients on hemodiafiltration. Homsak E; Ekart R Clin Chim Acta; 2018 Feb; 477():105-112. PubMed ID: 29221927 [TBL] [Abstract][Full Text] [Related]
11. Serum soluble ST2 is a promising prognostic biomarker in HBV-related acute-on-chronic liver failure. Jiang SW; Wang P; Xiang XG; Mo RD; Lin LY; Bao SS; Lu J; Xie Q Hepatobiliary Pancreat Dis Int; 2017 Apr; 16(2):181-188. PubMed ID: 28381383 [TBL] [Abstract][Full Text] [Related]
12. Predictive Value of GDF-15 and sST2 for Pulmonary Hypertension in Acute Exacerbation of Chronic Obstructive Pulmonary Disease. Lv Z; Liang G; Cheng M Int J Chron Obstruct Pulmon Dis; 2023; 18():2431-2438. PubMed ID: 37955023 [TBL] [Abstract][Full Text] [Related]
13. Soluble ST2 concentrations associate with in-hospital mortality and need for mechanical ventilation in unselected patients with COVID-19. Omland T; Prebensen C; Jonassen C; Svensson M; Berdal JE; Seljeflot I; Myhre PL Open Heart; 2021 Dec; 8(2):. PubMed ID: 34933965 [TBL] [Abstract][Full Text] [Related]
14. Increased Plasma Concentrations of Soluble ST2 Independently Predict Mortality but not Cardiovascular Events in Stable Coronary Heart Disease Patients: 13-Year Follow-up of the KAROLA Study. Pfetsch V; Sanin V; Jaensch A; Dallmeier D; Mons U; Brenner H; Koenig W; Rothenbacher D Cardiovasc Drugs Ther; 2017 Apr; 31(2):167-177. PubMed ID: 28283847 [TBL] [Abstract][Full Text] [Related]
16. Increased soluble ST2 predicts long-term mortality in patients with stable coronary artery disease: results from the Ludwigshafen risk and cardiovascular health study. Dieplinger B; Egger M; Haltmayer M; Kleber ME; Scharnagl H; Silbernagel G; de Boer RA; Maerz W; Mueller T Clin Chem; 2014 Mar; 60(3):530-40. PubMed ID: 24401186 [TBL] [Abstract][Full Text] [Related]
17. Association of Soluble Suppression of Tumorigenicity with No-Reflow Phenomenon and Long-Term Prognosis in Patients with Non-ST-Segment Elevation Acute Coronary Syndrome after Percutaneous Coronary Intervention. Zhang Q; Hu M; Ma S J Atheroscler Thromb; 2021 Dec; 28(12):1289-1297. PubMed ID: 33551392 [TBL] [Abstract][Full Text] [Related]
18. Risk prediction in pulmonary hypertension due to chronic heart failure: incremental prognostic value of pulmonary hemodynamics. Quan R; Huang S; Pang L; Shen J; Wu W; Tang F; Zhu X; Su W; Sun J; Yu Z; Wang L; Zhu X; Xiong C; He J BMC Cardiovasc Disord; 2022 Feb; 22(1):56. PubMed ID: 35172722 [TBL] [Abstract][Full Text] [Related]
19. Predicting long-term cardiovascular outcomes of patients with acute myocardial infarction using soluble ST2. Somuncu MU; Kalayci B; Avci A; Akgun T; Karakurt H; Demir AR; Avci Y; Can M Horm Mol Biol Clin Investig; 2020 Feb; 41(2):. PubMed ID: 32112700 [TBL] [Abstract][Full Text] [Related]
20. Serum suppression of tumorigenicity 2 level is an independent predictor of all-cause mortality in HIV-infected patients. Thiébaut R; Hue S; Le Marec F; Lelièvre JD; Dupon M; Foucat E; Lazaro E; Dabis F; Duffau P; Wittkop L; Surenaud M; Pellegrin I; Lacabaratz C; Bonnet F; Lévy Y; AIDS; 2017 Nov; 31(17):2355-2365. PubMed ID: 29068834 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]